SIOX

Sio Gene Therapies Inc. Common Stock
SIOX

Overview Fund Activity
Delisted

SIOX was delisted on the 22nd of March, 2023.

Back to rankings

39 hedge funds and large institutions have $19.1M invested in Sio Gene Therapies Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 17 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
39
Holders Change
-18
Holders Change %
-31.58%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
5
Increased
12
Reduced
17
Closed
23
Calls
$3.86M
Puts
$3.25M
Net Calls
+$608K
Net Calls Change
+$675K

Top Buyers

1
Citadel Advisors
1
Citadel Advisors
Florida
$3.93M
2
Hudson Bay Capital Management
2
Hudson Bay Capital Management
Connecticut
$3.43M
3
CS
3
Credit Suisse
Switzerland
$362K
4
Jane Street
4
Jane Street
New York
$289K
5
SIM
5
Spark Investment Management
New York
$230K

Top Sellers

1
CH
1
CVI Holdings
Delaware
$0
2
DM
2
Deerfield Management
New York
$0
3
JG
3
Jefferies Group
New York
$0
4
ECM
4
Endurant Capital Management
California
$0
5
MIM
5
Monashee Investment Management
Massachusetts
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Group One Trading
51
Group One Trading
Illinois
– -$46K -4,364 Closed
GF
52
Gabelli Funds
New York
– -$28K -2,596 Closed
Simplex Trading
53
Simplex Trading
Illinois
– -$20K -1,882 Closed
MWNA
54
Marshall Wace North America
New York
– -$16K -1,466 Closed
CG
55
Cutler Group
California
– -$13K -1,300 Closed
FANJ
56
Financial Architects (New Jersey)
New Jersey
– -$3K -294 Closed
Barclays
57
Barclays
United Kingdom
– -$3K -238 Closed
1 2
3